Drug news
FDA approves Lymphoseek (Navidea Biopharma) for intraoperative Lymphatic Mapping
The FDA has approved on 13 March 2013, Lymphoseek (technetium Tc 99m tilmanocept) Injection, from Navidea Biopharmaceuticals , a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with Breast Cancer or Melanoma who are undergoing surgery to remove tumor-draining lymph nodes.
Lymphoseek is an imaging drug that helps locate lymph nodes; it is not a cancer imaging drug. Lymphoseek is the first new drug used for lymph node mapping to be approved in more than 30 years.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins